Skip to content

Autologous Osteo-periosteal Cylinder Graft Transplantation for Hepple V Osteochondral Lesions of the Talus

Clinical Study of Autologous Osteo-periosteal Cylinder Graft Transplantation for Hepple V Osteochondral Lesions of the Talus

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03347877
Enrollment
70
Registered
2017-11-20
Start date
2018-01-01
Completion date
2026-12-31
Last updated
2025-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteochondral; Defect

Keywords

autologous osteo-periosteal cylinder graft, autologous osteochondral graft, randomized controlled trial, Hepple V osteochondral lesions of the talus

Brief summary

The trial evaluates the clinical efficacy and safety of autologous osteo-periosteal cylinder graft transplantation for Hepple V osteochondral lesions of the talus. Half of participants will receive autologous osteo-periosteal cylinder graft transplantation, while the other will receive osteochondral graft transplantation as a control group.

Detailed description

Autologous osteo-periosteal cylinder graft surface is a periosteal structure, with the ability of repairment to cartilage, periosteum is closely connected to the cortical bone, then the deep loose cancellous bone.The objective of the study is to evaluate the clinical efficacy of autologous osteo-periosteal cylinder graft transplantation for Hepple V osteochondral lesions of the talus by randomized controlled trial. 70 patients with clinically diagnosed Hepple V talus osteochondral lesions according to 1: 1 were divided into experimental group and control group. The experimental group will be treated with autologous osteo-periosteal cylinder graft transplantation under arthroscopy. The control group will be treated with autologous osteochondral graft under arthroscopy. The patients will be treated by the same surgeon in this study group. Postoperative MRI MOCART evaluation, clinical AOFAS score, VAS score, Tegner score, and the secondary arthroscopy ICRS score will be selected as the measures of outcome. The incidence of adverse events will be recorded.

Interventions

PROCEDUREautologous osteo-periosteal cylinder graft transplantation

Autologous osteo-periosteal cylinder graft transplantation is a novel treatment for Hepple V osteochondral lesions of the talus.

PROCEDUREautologous osteochondral graft transplantation

Autologous osteochondral graft transplantation is the most common treatment for Hepple V osteochondral lesions of the talus.

DEVICEautologous osteo-periosteal cylinder graft

Autologous osteo-periosteal cylinder graft is taken from ilium.

Sponsors

Peking University Third Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* 18-50 years old, male or female * Chronic pain in the ankle, confirmed by ankle joint MRI as Hepple V osteo-chondral lesions of the talus * Using rest/external use/oral non-steroidal anti-inflammatory drugs and other conservative treatment for more than 3 months ineffective * Patients voluntarily participated in clinical trials, signed informed consent, with clinical follow-up

Exclusion criteria

* In the last 6 months patients participated in other drug or medical device clinical trials * Line of force in ankle is not correct (varus or valgus\> 5 degrees) * Grade III ankle collateral ligament injury * Chronic specific synovitis (rheumatoid, pigmented villonodular synovitis, etc.) * Joint fibrosis, ankylosis, activity was significantly limited * Moderate and severe osteoarthritis * There are MRI contraindications * Hemophilia patients * The general condition of patients can not tolerate surgery * Pregnant or planned pregnant women and lactating women * Abnormal mental capacity without autonomy * Other conditions in which the doctor can not decide to participate in the trial

Design outcomes

Primary

MeasureTime frameDescription
American Orthopaedic Foot & Ankle Society(AOFAS) ankle-hindfoot score4 yearsAmerican Orthopaedic Foot & Ankle Society(AOFAS) ankle-hindfoot score. The higher score represent the better outcome.

Secondary

MeasureTime frameDescription
International Cartilage Repair Society(ICRS) score4 yearsInternational Cartilage Repair Society(ICRS) score. The higher score represent the better outcome.
Magnetic Resonance Observation of cartilage repair tissue(MOCART) score4 yearsMagnetic Resonance Observation of cartilage repair tissue(MOCART) score. The higher score represent the better outcome.
Tegner activity level score4 yearsThe highest level of activity that you participated in before your injury and the highest level you are able to participate in currently. The higher values represent a better outcome.
Visual analogue scale4 yearsThe visual analogue scale or visual analog scale (VAS) is a psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured. When responding to a VAS item, respondents specify their level of agreement to a statement by indicating a position along a continuous line between two end-points. From 0 to 10, no pain 0, worst pain imaginable 10. The higher values represent a worse outcome.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026